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Objective: To determine whether heart function in childhood is affected by exposure to 
methylmercury (MeHg) from seafood.   
Study design: Prospective study of a Faroese birth cohort (N = 1,022). Examinations at ages 7 
and 14 years included blood pressure, heart rate variability (HRV) and its frequency components 
of autonomic origin, and brainstem auditory evoked potentials (BAEP).   Mercury concentrations 
were determined in cord blood, and in the child’s hair.   
Results: Both low-frequency (LF) and high-frequency (HF) activities decreased by about 25% 
from 7 to 14 years; they correlated well with the blood pressures.  A doubling of prenatal MeHg 
exposure was associated with a decrease in LF and HF powers of about 6.7 % (p = 0.04) and in 
the coefficient of variation of the R-R interval of 2.7% (p = 0.04) at age 14 years. No discernible 
effect on blood pressure was apparent.  Decreased LF variability was associated with increased 
latency of BAEP peak III, but adjustment for MeHg exposure substantially attenuated this 
correlation.  
Conclusions: MeHg exposure was associated with decreased sympathetic (LF) and 
parasympathetic (HF) modulation of the HRV.  Parallel MeHg-related delays of BAEP latencies 
may be due to underlying MeHg neurotoxicity to brainstem nuclei.   
 
BAEP Brainstem auditory evoked potentials 
C-CVHF Component coefficient of variance for the high-frequency band 
C-CVLF Component coefficient of variance for the low-frequency band 
CVRR Coefficient of variation for the R-R interval 
HF High frequency 
HRV Heart rate variability 
LF Low frequency 
MeHg Methylmercury 
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A National Research Council committee recently suggested that cardiovascular function may be 
vulnerable to developmental methylmercury (MeHg) exposure.1  The evidence reviewed included 
a prospective birth cohort study from the Faroe Islands, where an increase in blood pressure and a 
decrease in the coefficient of variation for the R-R interval (CVRR) at age 7 years was observed 
at increased intrauterine exposure levels.2  In the same children, MeHg exposure was also 
associated with delayed brainstem auditory evoked potential latencies3 and deficits in 
neuropsychological tests that reflect attention and several other functional modalities.4  
 The CVRR and its frequency components are easy to apply and highly reproducible in 
children.5-9  Sympathetic hyperactivity and parasympathetic hypoactivity have been documented 
in connection with cardiovascular diseases.6,10  The CVRR increases with age up to 6-10 
years,11,12 followed by a decrease related to reduced parasympathetic activity.13  Boys have a 
greater CVRR than girls,13 and HRV is increased by physical training.14  However, very little 
information on children is available regarding the sensitivity of HRV to toxicants, especially 
those that may affect the nervous system. 
 In adults, HRV is sensitive to dysfunctions of autonomic tone in smokers15-17 and 
alcohol drinkers.17-20  Abnormalities have also been documented after exposure to neurotoxic 
agents, such as MeHg, mercury vapor, other metals, certain solvents, and nerve gases.21-28  In 
most cases, the CVRR was apparently affected mainly through a relative depression of 
parasympathetic activity.21  In particular, a decreased HRV in adult patients that had been born 
with congenital MeHg poisoning appeared to be mainly due to parasympathetic hypofunction.29  
Lesions located in the brainstem may affect the HRV,30 and neuropathological abnormalities 
caused by developmental MeHg exposure include this location.31  
 In a prospective study of a birth cohort with increased intrauterine exposure to MeHg, 
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exposure-associated changes in CV-RR and blood pressures were recorded at age 7 years.2  This 
population has now been re-examined at age 14 years with electrophysiologic parameters of heart 
function, blood pressure and evoked potentials.  In addition, CVRR data from both examinations 
were analyzed in regard to the frequency components.  It was hypothesized that MeHg exposure 
would affect HRV and blood pressure, and that effects, if mediated through brainstem nuclei, 
would be associated with known MeHg-related delays in BAEP latencies. 
 
METHODS      
Study Population and Follow-up 
A cohort of 1,022 births was assembled in the Faroe Islands during a 21-month period of 1986-
1987.32  The first follow-up examination was carried out seven years later and included 
determination of HRV and evoked potential latencies, neuropsychological testing, pediatric 
examination, and exposure assessment.2-4  At age 14 years, a total of 878 of 1,010 live cohort 
members (86.9%) were examined by comparable methods (Table I).33  The examinations were 
conducted by a team of health professionals who had no access to information on individual 
exposure levels.  The 438 boys and 440 girls examined had an average age of 13.83 (SD, 0.32) 
years.  The two examinations involved a total of 963 cohort children (483 boys and 480 girls), of 
whom 813 (402 boys and 411 girls) were examined twice.   
 In a small number of cases, complete heart rate records were not obtained.  One child 
had a very high systolic blood pressure and was referred to a specialist.  When re-examined 
several weeks later, the blood pressure had substantially decreased, but matching HRV data were 
not obtained, and the child was therefore excluded.  One child with a low birth weight2 and 18 
other children diagnosed with neurological or other serious diseases that may affect the nervous 
 5
system33 were excluded.  None of the children had diabetes.  
 At each examination, a questionnaire was filled in by a parent and provided information 
about past medical history and other relevant factors.  Physical activity was rated much, average 
and none, with all children participating in such sports as soccer being rated ‘much’.  The 
pediatrician interviewed the child about smoking and use of alcohol.  Birth weight, family history 
of hypertension / maternal hypertension (maternal hypertension risk), and smoking during 
pregnancy were previously recorded.2  The study protocol was approved by the ethical review 
committee for the Faroe Islands and the Institutional Review Board at Boston University, and 
parental informed consent was obtained.  
 The primary indicator of intrauterine exposure to MeHg was the mercury concentration 
in cord blood; it was supplemented by the concentration in maternal hair at parturition.32  
Exposure levels varied widely, with a 1,000-fold difference between the lowest and the highest 
mercury concentrations.32  Children participating in the follow-up had prenatal exposures similar 
to those recorded for the full cohort.33  Analysis of hair obtained at the two follow-up 
examinations showed that the intrauterine exposure level averaged about 7-fold and 4-fold higher 
than the two sets of postnatal levels.33  Results given in g may be converted to nmol by 
multiplying by 5.0.   
 
Cardiovascular Function Assessment  
Two pediatricians carried out a thorough physical examination that included assessment of 
systolic and diastolic blood pressures thrice, and the average was calculated.  With the child 
relaxing in a chair, a cuff that covered between 1/2 and 2/3 of the upper arm was applied on the 
left arm, and the pressures were read in mm Hg on a sphygmomanometer.  Body weight was 
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measured in kg on an electronic scale to the nearest single digit after the decimal point.  Standing 
height was measured with a stadiometer to the nearest millimeter. 
 At both examinations, the heart rate was measured as the average R-R interval on an 
electrocardiographic amplifier (NEC-Sanei 1271SP) connected to a computer.2  After the child 
had been lying in a relaxed, supine position and breathing normally for at least 5 min, 300 R-R 
intervals were measured in real time (sampling time, 1 ms); 100 consecutive R-R intervals with 
the minimal standard deviation were automatically extracted for calculation of the average heart 
rate and its relative standard deviation (SD).  The CVRR is the ratio of the SD of the R-R 
intervals to the average value (RRmean).   
 The cardiac sinus rhythm shows fluctuations around the mean heart rate due to 
continuous changes in the autonomic balance.34-36  The main periodic fluctuations consist of the 
respiratory sinus arrhythmia and the baroreflex-related heart rate variation at a lower frequency.  
Their frequencies reflect the dependence on inspiratory inhibition of the vagal tone, and the 
slower rhythm originating from intrinsic oscillation in the vasomotor part of the baroreflex loop.  
They therefore indicate parasympathetic and sympathies activities.  Spectral analysis can provide 
estimates of the frequencies and powers (e.g., the magnitude of a cyclical component) from time-
series data.  We therefore applied autoregressive spectral analysis to partition the HRV into 
independent components.17,37  The results of the autoregressive spectral analysis were expressed 
in low frequency (LF) and high frequency (HF) components, i.e., 0.01-0.15 Hz and 0.15-0.40 Hz.  
As the square root of the total power spectral density is equal to the standard deviation of the R-R 
intervals, each component coefficient of variation (i.e., C-CVLF and C-CVHF) was defined as 
the ratio of the square root of each component power spectral density (PSD-LF and PSD-HF in 
ms2) to the RRmean: C-CVLF (or C-CVHF) = 100 * sqrt (PSD-LF (or PSD-HF))/RRmean.  The 
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LF/HF power ratio indicates the balance of cardiac autonomic activity, with LF/HF>>1 and 
LF/HF<<1 reflecting sympathetic and parasympathetic prominence, respectively. 
 Of 841 subjects with HRV data at age 14, BAEPs were recorded in all but two, and in all 
of the 781 children who were also examined at age 7 years.  A four-channel electromyograph 
(Medelec Sapphire-4ME) was employed as previously described.33  Peak III latency at 20 Hz and 
40 Hz at both examinations showed delays associated with intrauterine MeHg exposure.2,33  Peak 
III is thought to reflect the volume-conducted electric activity from the pons (superior olivary 
nucleus).38  
 
Data Analysis 
Because of skewed distributions, logarithmic transformation of the contaminant concentrations 
was used to limit the dependence upon small numbers of children with very high exposure levels. 
Likewise, outcome variables other than blood pressure and heart rate required logarithmic 
transformation to obtain a better fit of the regression models. For transformed variables, 
geometric means were supplemented by interquartile ranges (25th and 75th percentiles).  
Pearson’s correlation coefficients were used to assess bivariate relationships, and adjustment for 
confounders was included in partial correlation coefficients. Differences between paired 
examination data were assessed by matched-pairs t test, while those between sexes were analyzed 
by unpaired t-test.   
 Regression analysis was carried out to determine the association between MeHg 
exposure and the outcome variables.  Birth weight, maternal hypertension risk and maternal 
smoking during pregnancy, and the child’s age, sex, height and weight were included as 
confounders.  Tanner stage was assessed at age 14 years but was not included because of the 
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close association with age and anthropometric parameters, and because this variable was missing 
from several subjects.  Additional covariates at age 14 years were regular smoking (information 
was missing from 31 subjects), and physical activity rated ‘much’.  Blood pressure was adjusted 
for examiner.  
 For log transformed outcome variables, the MeHg regression coefficients were modified 
to indicate the relative change (in percent) of the average of the dependent variable associated 
with a doubling of the MeHg exposure.  The heart rate was subsequently added in models where 
other outcomes were used as effect parameters.  To determine whether changes between the two 
examinations were associated with MeHg exposure, the paired result obtained seven years before 
was introduced as predictor of the outcome at age 14 years.  Potentially nonlinear exposure-effect 
relationships2 were again explored in generalized additive models, which do not require linearity 
assumptions while providing a smooth non-parametric dose-response curve.39  
 
RESULTS 
HRV Changed with Age but Remained a Significant Predictor of Blood Pressure 
Paired HRV results from ages 7 and 14 years showed substantial changes between the two 
examinations, with decreases of about 25% in both low frequency (LF) and high frequency (HF) 
powers and their variabilities (Table II).  However, the paired data on heart rate, CVRR, and the 
HF power correlated well.  Boys and girls generally had similar results, except for a higher heart 
rate in girls at 7 years and a higher systolic blood pressure in boys at 14 years.   
 A lower CVRR, a lower HF power, and a higher LF / HF ratio were significant 
predictors of increased systolic blood pressure at both examinations, and a lower LF power was 
also significant at age 7 (Table III).  Diastolic blood pressure was only weakly related to the HRV 
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parameters.   
Both LF and HF Decreased at Higher MeHg Exposures 
 Adjusted regression coefficients showed significant negative impacts of MeHg on 
several parameters (Table IV).  Both LF and HF decreased at higher prenatal MeHg exposure.  
Postnatal exposure at age 7 years seemed mainly related to LF, while mainly to HF at age 14 
years.  Inclusion of more than one MeHg exposure indicator as independent variables resulted in 
attenuated MeHg regression coefficients in the same direction.  The correlation between prenatal 
and postnatal exposures (correlation coefficients of 0.33 and 0.35)33 therefore did not allow a 
clear separation of the impact of exposures at different developmental stages.   
 A non-linear association between prenatal MeHg exposure and blood pressure and 
CVRR was previously found at age 7 years, where the strongest effect was seen at cord-blood 
concentrations below 10 g/L.2  This association was again explored using generalized additive 
models.  Fig 1 shows that, while significant at age 7 years,2 the effect on blood pressure is no 
longer significant at age 14 years.  However, similar modeling of CVRR showed that an effect of 
prenatal MeHg exposure is clearly present also at age 14 years (Fig 2).  While the change in 
CVRR within the low-level exposure range below 10 g/L was not statistically significant, the 
heart rate increased by 2.67 (95% CI, 0.08; 5.27) for each doubling in MeHg exposure within that 
interval.  Heart rate was associated with almost all outcomes, but adjustment for this variable 
resulted in only marginal changes of the MeHg regression coefficients.  However, when the 
previous outcome at age 7 years was included as an additional independent variable, the MeHg 
effects on the same outcome at 14 years was attenuated and became non-significant. 
LF Power Was Associated with BAEP Latencies 
 To ascertain possible associations with brainstem functions, correlations were calculated 
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with the latency of BAEP peak III, which appears to be increased by prenatal MeHg exposure.3,33  
The LF power and its component CV showed clear negative associations with peak III latencies, 
viz., the greater the BAEP latency, the less the LF power and its CV (Table V).  To determine 
whether these associations were innate, partial correlation coefficients were calculated with 
adjustment for prenatal and postnatal MeHg exposure biomarkers.  These adjusted correlations 
were substantially attenuated and tended to lose statistical significance. 
 
DISCUSSION 
This prospective study of a birth cohort provides information on developmental changes in 
cardiac autonomic activity and on the impact of MeHg neurotoxicity.  A major advantage of the 
present study is that birth cohort members were examined prospectively first at school age and 
then at early adolescence.  Maturation of the cardiac autonomic activity results in an increase in 
the CVRR with gestational age and during early postnatal life,34 then followed by a decline of 
CVRR as well as in C-CVLF and C-CVHF.  Infants particularly have a high sympathetic activity 
that then decreases between ages 5 and 10 years, while the sympatho-vagal balance as expressed 
by the LF / HF ratio changes less.12  The age-related decreases in heart rate, CVRR, C-CVHF, 
and HF power now documented are in accordance with the expectation from smaller, cross-
sectional studies.9,11-13  Despite maturation changes, the CVRR and HF results at the two 
examinations correlated well, although the LF results varied more.  The blood pressure levels and 
the age-associated increase in systolic blood pressure are in accordance with data from previous 
cross-sectional studies.40  Only limited sex-related differences were seen at the two ages 
examined, while some,9,12  but not all,17,21 previous studies reported an HRV difference between 
small numbers of boys and girls.  An increased LF / HF ratio is thought to act as a predictor of 
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increased blood pressure,10  and the results of the present study support this notion by the 
significant associations between increased systolic blood pressure and decreases in CVRR and 
HF results.  Conversely, physical training has been reported decrease blood pressures and 
increase both LF and HF powers.14  Again, the present results are in agreement with previous 
research.  
 Only sparse information is available on adverse effects on HRV in children, e.g., 
following developmental exposure to neurotoxicants.  The paucity of information is perhaps not 
surprising, given the substantial age-dependency of the HRV parameters that might complicate 
interpretation of cross-sectional studies.  Studies of adults with occupational exposure to 
neurotoxicants21-28 clearly show that HRV may be affected by chemical exposures that damage 
the nervous system.  However, effects on children would be difficult to predict from studies 
conducted in adults. 
 A central origin of autonomic oscillations of the HRV is indicated by experimental 
data41 and by decreases in HRV parameters in relation to central damage of the brainstem nuclei 
associated with autonomic nervous function.30  In a study of lead-exposed workers, 
electrophysiological parameters showed a significant exposure-associated HRV depression, 
although not the anticipated delayed latencies of BAEP peaks.24  This finding may suggest that 
changes in HRV could be an earlier effect than increased BAEP latencies.  Another study of 
occupational lead exposure reported an association between lead-induced changes in HRV and 
peripheral nerve conduction.42  
 The impact of prenatal MeHg poisoning on HRV has recently been documented in 
survivors who had reached adult age.29  Although only a small number of patients was examined, 
a significant decrease in HF results was reported as a lasting abnormality.  The present study 
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deals with a much larger number of subjects exposed to much lower levels of MeHg from 
contaminated marine food.  At both examinations, both HF and LF components appeared to be 
affected, but the effect on LF seemed to be less at age 7 years.  A difference in sensitivity of 
HRV components could be due to normal age-related changes in cardiac autonomic activity.  
Despite significant associations between exposure indicators and several HRV outcomes, a 
MeHg effect on blood pressure previously documented at age 7 years2 was not discernible at age 
14 years.  Also, the significant associations of 14-year outcomes with prenatal MeHg exposure 
were attenuated after adjustment for the 7-year outcomes.  Thus, the developmental MeHg 
exposure did not result in substantial further changes beyond those observed at age 7 years. 
 The plausibility of the findings reported here is supported by the strong evidence of 
MeHg neurotoxicity.1,29,31  Children with acute mercury vapor poisoning often have increased 
heart rate and increased blood pressure.43  In rats exposed to high doses of MeHg chloride, 
changes in normal heart rate variations were induced,44 and an increase in systolic blood pressure 
seen in another study persisted for at least 9 months.45  
 A link between brainstem functions and autonomic tone is supported by the associations 
in the present study between BAEP latencies and HRV parameters, especially the LF results.  
Although only weak and mostly non-significant after adjustment for MeHg exposure, the 
possibility cannot be completely discounted that such correlations are normal and unrelated to 
neurotoxicant exposures.  However, the fact that MeHg affects both parameters would suggest 
that the exposure-related changes in HRV at least in part reflect MeHg neurotoxicity exerted in 
the brainstem nuclei.  In addition, the existence of neurotoxic effects on the brainstem is 
suggested by highly significant MeHg-associated deficits in neuropsychological tests of 
attention.4  This hypothesis therefore deserves to be examined in experimental studies.  
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 While HRV parameters are highly reproducible under standardized conditions,5-9 a 
possible limitation of the present study is that HRV was assessed only during a brief period, and 
that respiratory patterns were not controlled.  Respiratory activity may have affected the HF 
component,34,35 but the children examined were resting in a darkened room, and the 100-heart-
beat sequence with the lowest variation was selected for statistical analysis.  Also, the time of the 
testing, relation to meals and exercise, temperature of the laboratory, etc., have limited effects on 
HRV results.35  Some circadian variation has been described,13 but the cohort children were all 
examined between 8 a.m. and 5 p.m., where the variation is expected to be the least.  While some 
HRV results may be positively associated with heart rate,17 adjustment for this variable affected 
the MeHg regression coefficients only slightly.  Also, by examining the CVRR rather than the 
RR itself, an adjustment for dependence on heart rate was included.  As mentioned above, age is 
known to affect HRV results, but at the time of each examination, the subjects were of virtually 
the same age, and both age and sex were incorporated as mandatory covariates in the statistical 
analyses.  At age 14 years, Tanner stage was not an important predictor, but rapid changes in 
height, weight, and other developmental factors at puberty age may have decreased the sensitivity 
of the study in identifying puberty-related effects on, e.g., blood pressure.  CVRR and other HRV 
parameters may be affected by alcohol and smoking habits,15-20 but few of the subjects examined 
had used tobacco and alcohol, and adjustment for smoking was included as a covariate.  While 
several diseases, such as congenital heart disease6 and asthma,8 are known to affect the CVRR, 
this cohort was population-based, and children with relevant diagnoses were excluded.   
 An important short-coming is that MeHg exposure was assessed only at three points in 
time, and that correlations between the three measures prevented distinction between effects of 
prenatal and postnatal exposures.  Most likely, the three biomarkers are imprecise indicators of 
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the MeHg concentrations that may have caused the effects during the 14-year lifespan of the 
children.  Such non-differential misclassification is likely to bias the finding toward the null 
hypothesis.  Thus, the present study has the advantage of size, prospective follow-up, and 
adjustment for relevant confounders.  However, imprecision, especially of the exposure 
assessment would tend to cause an underestimation of the true MeHg effects. 
 Clinical studies of adults have reported that a decreased cardiac vagal tone is associated 
with an increased risk of sudden cardiac death or coronary artery disease, and measurements of 
HRV and the quantification of its spectral components are therefore considered powerful 
predictors of cardiovascular morbidity and mortality.35  Recent findings in adults suggest that 
MeHg exposure is associated with increased cardiovascular mortality.46,47  Although several toxic 
mechanisms may be involved, these findings in conjunction with the present study suggest that 
the impact of neurotoxic MeHg effects on autonomic regulation of heart function deserves 
attention.   
 
We are grateful to the cohort families for their loyal support, and to Drs Nicolina Sørensen and  
Flemming Juul Hansen and the highly competent clinical staff in Tórshavn.  
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Table I.  Characteristics of 424 boys and 433 girls from the Faroese birth cohort examined at age 
14 years 
 
 
Variable  
 
Maternal age in years  27.4 (5.4) 
Previous births (none / one / at least two in %) 33.4 / 34.5 / 32.1 
Smoking during pregnancy (no / yes in %) 59.3 / 40.7 
Alcohol consumption during pregnancy (never / ever in %) 76.5 / 23.5 
Gestational age in weeks  40.3 (1.3) 
Birth weight in g  3680 (528) 
Age at 7-year examination in years*  6.84 (0.31) 
Body weight in kg* 24.45 (3.85) 
Height in cm* 122.4 (5.07) 
Age at 14-year examination in years  13.83 (0.32) 
Year of examination (% in 2000 / 2001) 55.8 / 44.2 
Body weight in kg 54.58 (11.20) 
Height in cm 162.9 (7.26) 
Smoking (no / yes in %) 94.6 / 5.4 
 
Data for continuous variables are given as mean (SD). 
*Data for 401 boys and 411 girls who were also examined at age 7 years 
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Table II.   Cardiovascular function results in boys and girls at 7 years and 14 years after exclusion of children with relevant diagnoses.  
For blood pressures and heart rate, the results are given as mean (SD).  For the other outcomes, data are given as geometric mean 
(interquartile range).   
 
 
7 years  
 
14 years 
 
 
 
Parameter 
 
 
Boys 
 
Girls 
  
 
Boys 
 
 
Girls 
 
 
Correlation 
coefficient§ 
 
Systolic blood pressure (mm Hg) 
Diastolic blood pressure (mm Hg)
Heart rate (min-1) 
CVRR (%) 
LF power (n.u.) 
HF power (n.u.) 
LF / HF 
C-CVLF 
C-CVHF 
100.2 (8.02)* 
64.7 (8.63) 
80.7 (9.52)*† 
7.62 (5.17-11.53)* 
954 (481-2130) 
1779 (807-5270)* 
0.539 (0.273-1.007)
4.13 (2.96-5.99)* 
5.64 (3.78-8.97)* 
100.0 (8.57)* 
65.0 (8.38) 
85.0 (10.93)* 
7.93 (5.55-11.42)* 
1076 (475-2457)* 
1787 (709-5025)* 
0.603 (0.302-1.232) 
4.61 (3.18-6.57)* 
5.94 (4.11-9.25)*  
115.5 (8.27)† 
63.1 (8.45) 
69.6 (10.86) 
5.91 (4.26-8.17) 
829 (413-1833) 
1252 (578-2826) 
0.663 (0.343-1.341) 
3.31 (2.39-4.86) 
4.06 (2.89-5.88) 
113.0 (7.88) 
64.1 (7.80) 
71.5 (10.96) 
6.16 (4.58-8.25) 
849 (439-1796) 
1439 (644-3312) 
0.590 (0.320-1.101) 
3.43 (2.51-4.99) 
4.47 (3.26-6.09) 
0.319 
0.194 
0.437 
0.406 
0.249 
0.406 
0.190 
0.210 
0.374 
*p < 0.01 for difference between outcome at ages 7 and 14 years for fixed sex; †p < 0.01 for difference between outcome in boys and 
girls at the same age; §Partial correlation coefficient (after logarithmic transformation of HRV parameters) with adjustment for sex, 
blood pressure also adjusted for examiner (p < 0.0001) 
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Table III.   Heart rate variability parameters (log transformed) as predictors of blood pressures in 
Faroese cohort members at 7-year and 14-year examinations.  Results are given as partial 
correlation coefficients adjusted for sex and (at age 14 years) examiner (P value).   
 
 
7 years 
 
14 years 
 
 
 
Parameter 
 
Systolic 
 
Diastolic 
 
Systolic 
 
Diastolic 
CVRR  
LF power  
HF power  
LF / HF 
C-CVLF 
C-CVHF 
-0.12 (<0.001) 
-0.09 (0.006) 
-0.13 (<0.001) 
  0.07 (0.031) 
-0.07 (0.040) 
-0.12 (<0.001) 
-0.09 (0.012) 
-0.07 (0.040) 
-0.07 (0.051) 
 0.01 (0.842) 
-0.05 (0.117) 
-0.06 (0.096) 
-0.07 (0.030) 
-0.03 (0.427) 
-0.13 (<0.001) 
  0.12 (<0.001)
 0.01 (0.800) 
-0.11 (0.002) 
-0.05 (0.175) 
 -0.03 (0.420) 
-0.06 (0.072) 
  0.04 (0.242) 
  0.00 (0.944) 
-0.04 (0.292) 
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Table IV.  Estimated effects of a doubling of MeHg exposure as indicated by three different 
exposure biomarkers after adjustment for confounders (p value).  For log transformed HRV 
outcomes, the effect is expressed as the relative change (%) in the untransformed variable.   
 
Outcome 
  
 
Cord blood 
 
 
Hair at 7 yrs 
  
 
Hair at 14 yrs
 
 
7 years  
 
    
 
Heart rate (min-1)  
 
0.250 (0.38) 
 
-0.029 (0.90)  
 
- 
 
CVRR*   
 
-1.27 (0.36) 
 
-0.344 (0.76)  
 
- 
 
LF power*   
 
-5.98 (0.047) 
 
-5.13 (0.041)  
 
- 
 
HF power*   
 
-5.16 (0.19) 
 
-0.179 (0.96)  
 
- 
 
LF / HF*  
 
-0.860 (0.79) 
 
-4.95 (0.055)  
 
- 
 
C-CVLF*  
 
-2.81 (0.052) 
 
-2.67 (0.025)  
 
- 
 
C-CVHF*   
 
-2.38 (0.19) 
 
-0.159 (0.92)  
 
- 
 
14 years  
 
 
 
  
 
 
 
Systolic blood pressure (mm Hg)  
 
0.045 (0.84) 
 
0.040 (0.83)  
 
-0.017 (0.91) 
 
Diastolic blood pressure (mm Hg)  
 
0.121 (0.60) 
 
0.018 (0.93)  
 
-0.086 (0.61) 
 
Heart rate (min-1)  
 
0.355 (0.26) 
 
0.393 (0.13)  
 
0.408 (0.073) 
 
CVRR*   
 
-2.73 (0.035) 
 
-1.12 (0.30)  
 
-1.52 (0.11) 
 
LF power*   
 
-6.70 (0.038) 
 
-2.97 (0.27)  
 
-2.06 (0.40) 
 
HF power*   
 
-6.78 (0.038) 
 
-4.70 (0.088)  
 
-4.61 (0.056) 
 
LF / HF*  
 
0.112 (0.97) 
 
1.82 (0.45)  
 
2.69 (0.21) 
 
C-CVLF*  
 
-2.90 (0.070) 
 
-0.978 (0.47)  
 
-0.483 (0.68) 
 
C-CVHF*  
 
-2.95 (0.046) 
 
-1.87 (0.13)  
 
-1.79 (0.099) 
* Log transformed
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Table V.  Sex-adjusted partial correlation coefficients (p value) for paired results of brainstem 
auditory evoked potential peak latency III in relation to cardiovascular parameters at the 14-year 
examination, with blood pressures also adjusted for examiner, before and after additional 
adjustment for mercury exposure.  
 
 
Outcome 
  
 
Sex adjusted 
 
 
Adjusted also for mercury 
  
 
Systolic blood pressure  
 
-0.05 (0.14) 
 
-0.04 (0.30)  
 
Diastolic blood pressure  
 
-0.01 (0.82) 
 
-0.04 (0.26)  
 
Heart rate   
 
-0.09 (0.007) 
 
 -0.07 (0.042)  
 
CVRR*   
 
-0.01 (0.67) 
 
 0.00 (0.95)  
 
LF power*   
 
-0.06 (0.073) 
 
-0.04 (0.33)  
 
HF power*   
 
0.03 (0.37) 
 
 0.03 (0.43)  
 
LF / HF*  
 
-0.11 (0.002) 
 
 -0.07 (0.040)  
 
C-CVLF*  
 
-0.09 (0.009) 
 
-0.06 (0.11)  
 
C-CVHF*   
 
 0.01 (0.86) 
 
 0.01 (0.79)  
* Log transformed 
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Fig 1.  Generalized additive model for prenatal MeHg exposure (indicated by the mercury 
concentration in cord blood) as predictor of blood pressures at ages 7 and 14 years after 
adjustment for confounders.  Broken lines depict the averages at age 7, while dotted lines indicate 
95% confidence limits for the 14-year results.   
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Fig 2.  Generalized additive model with 95% confidence limits for prenatal MeHg exposure 
(indicated by the mercury concentration in cord blood) as predictor of the CVRR at 14 years of 
age after adjustment for confounders.  
 
